Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Basket Trial of Neratinib Plus Trastuzumab Biosimilar (Herzuma) in HER2-Mutated Advanced Solid Tumors
KCT0006038Phase 2Completed
- Sponsor
- Ministry of Health & Welfare
- Start
- May 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of neratinib, trastuzumab in Nonhematologic neoplasms, sponsored by Ministry of Health & Welfare. Started May 2021; status: completed.
02
Drugs
neratinibtrastuzumab
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on KCT0006038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006038.